The company is co-headed by Jenny Xiao, an early employee and researcher at OpenAI. She’s partnering with Jay Zhao, a veteran venture investor who counts on an analysis-first approach to try and ...

(Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, ...

Conference ID: BAIN All participants will need to reference “Bain Capital Specialty Finance - Second Quarter Ended June 30, 2025 Earnings Conference Call” once connected with the operator.

The latest international Bain Capital Partners XII, LLC news and views from Reuters - one of the world's largest news agencies ...

Bain Capital and Bristol Myers Squibb are providing financial and scientific support to a new startup working on autoimmune drugs.

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.

(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing ...

Lincoln National Corporation (NYSE:LNC), a leading U.S. provider of insurance and retirement solutions, is advancing its strategy in 2025 through a major partnership with Bain Capital.

Bristol Myers Squibb (NYSE: BMY, “BMS”) and Bain Capital today announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new therapies for ...

Bain Capital and Bristol Myers Squibb form new biopharma company The newly formed company launches with a $300 million financing commitment led by Bain Capital.

Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”) today announced it will report its financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 ...

Bain Capital and Botanic Properties have broken ground on a unique biomanufacturing facility in Bedford, Mass., which is designed to house multiple companies operating separately in highly ...